Today's pre-market stock movers: TLRY, ACB, CGC and more

• $Tilray Brands (TLRY.US)$ +17.2% $Aurora Cannabis (ACB.US)$ +13.61% $Canopy Growth (CGC.US)$ +10% $Cronos Group (CRON.US)$ +6.5% $Etfmg Alternative Harvest Etf (MJ.US)$ +6.1% $GrowGeneration (GRWG.US)$ +5.3% . ( The House Rules Committee has scheduled a Monday-afternoon meeting to prepare a federal marijuana legalization bill for floor action.)

• $OrganiGram (OGI.US)$ +6.6% (provides corporate update and announces new product launches)

• $Titan International (TWI.US)$ +3.3% (TWI and CNHI enter into long-term supply agreement)

• $Shaw Communications (SJR.US)$ +2.5% (comments on critical milestone toward closing transaction with Rogers Communications (RCI); CRTC approves transfer of broadcasting undertakings to Rogers)

• $Jazz Pharmaceuticals (JAZZ.US)$ +1.2% (invests $100 mln in in UK Manufacturing facility)

• $Novocure (NVCR.US)$ +1% (presents updated results from Phase 2 2-THE-TOP trial)

• $Farfetch (FTCH.US)$ +2.6% (upgraded to Buy from Hold at Societe Generale)

• $The Honest (HNST.US)$ -18.87%, $Altus Power (AMPS.US)$ -9.62%, $Orion Office Reit (ONL.US)$ -13.9%, $SmartRent (SMRT.US)$ -10.6% (also acquires SightPlan for $135 mln) $Maxeon Solar Technologies (MAXN.US)$ -8.8% $Rocket Lab (RKLB.US)$ -1% (lowers Q1 rev guidance due to weather-related launch delay)

• $MEI Pharma (MEIP.US)$ -46.1% (MEIP and Kyowa Kirin provide regulatory update on zandelisib; FDA discourages filing based on Phase 2 TIDAL study data)

• $DigitalBridge Group (DBRG.US)$ -17.9% (acquires Telenet's Mobile Telecommunications Tower Business)

• $Purple Innovation (PRPL.US)$ -8.8% (prices offering 14.0 mln shares of common stock; additional terms not disclosed)

• $Gates Industrial (GTES.US)$ -5.3% (prices secondary offering of 5.0 mln ordinary shares by certain selling stockholders affiliated with Blackstone (BX))

• $JD.com (JD.US)$ -4.4% (provides details of JD Logistics' financing)

• $Nouveau Monde Graphite (NMG.US)$ -3.1% (provides quarterly update; Year-end cash position of $62.3 mln)

• $Arcutis Biotherapeutics (ARQT.US)$ -2.8% (says Roflumilast demonstrates clinically meaningful results in patients with Seborrheic Dermatitis)

• $SEI Investments (SEIC.US)$ -2.1% (HSBC Private Bank terminates one of its agreements)

• $Asana (ASAN.US)$ -1.4% (files mixed securities shelf offering)